Sun Pharma and Philogen Enter into Global Licensin...
Category : Licensing/Collaboration Deal 4 October 2024Sun Pharma and Philogen enter into a global Exclusive Commercialization, License, and Supply Agreeme...
Sun Pharma and Philogen enter into a global Exclusive Commercialization, License, and Supply Agreeme...
Sapience Therapeutics begins patient enrolment in phase 2 study of first-in-class ß-catenin an...
US FDA accepts and grants priority review status to AstraZeneca’s sNDA for Calquence to treat...
Photocure partner Asieris unveils Cevira phase III subgroup analysis by age groups at the 2024 CSCO...
Tessellate BIO, Omico & CMRI collaborate to accelerate discovery of synthetic lethal precision t...